SLC7A8 / LAT2 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-SLC7A8 / LAT2 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificitySLC7A8 / LAT2
Clone[4H10]
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgG1
FormatProtein A purified
Size0.05 mL
Concentration0.65 mg/ml
ApplicationsImmunohistochemistry (IHC) Paraffin, Immunofluorescence (IF), Immunoprecipitation (IP), Flow Cytometry (FC/FACS)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: Human SLC7A8. SLC7A8 Antibody, HLAT2 Antibody, LPI-PC1 Antibody, Integral membrane protein E16H Antibody Description: Sodium-independent, high-affinity transport of small and large neutral amino acids such as alanine, serine, threonine, cysteine, phenylalanine, tyrosine, leucine, arginine and tryptophan, when associated with SLC3A2/4F2hc. Acts as an amino acid exchanger. Has higher affinity for L-phenylalanine than LAT1 but lower affinity for glutamine and serine. L-alanine is transported at physiological concentrations. Plays a role in basolateral (re)absorption of neutral amino acids.
ImmunogenImmunogen Description: Full length human recombinant protein of human SLC7A8 (NP_036376) produced in HEK293T cell. Immunogen Type: Recombinant protein
Other Names[Mouse [clone 4H10] (IgG1) to Human SLC7A8 / LAT2; Human SLC7A8 / LAT2; HLAT2; LPI-PC1; Integral membrane protein E16H], [SLC7A8; SLC7A8; LAT2; LPI-PC1; LAT2; hLAT2]
Gene, Accession #[SLC7A8 / LAT2], Gene ID: 23428, NCBI: NP_036376.2, UniProt: Q9UHI5
Catalog #MBS249318
Price$530
Order / More InfoSLC7A8 / LAT2 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.